Prophylactic medical treatment of patent ductus arteriosus with ibuprofen is not indicated

Introduction: Patent ductus arteriosus (PDA) is still one of the most common problems found in preterm infants. It often complicates the clinical course of preterms and increases the risk of intraventricular hemorrhage (IVH), necrotizing enterocolitis (NEC), chronic lung disease (CLD) and death. However, there continues to be controversy as to the appropriate indications and means for treatment varying from prophylaxis to treatment only when a PDA is demonstrably significant. Aim of the study: To determine that prophylactic use of Ibuprofen in closure of PDA is not indicated because of a high closure rate after…